早期乳腺癌患者心肺适能与放疗相关疲劳:一项前瞻性先导研究
该前瞻性先导研究纳入28例接受乳腺放疗的Tis-T2N0M0期乳腺癌患者,在放疗期间或刚结束时行症状限制性心肺运动试验测峰值摄氧量(VO2peak),并以FACIT疲劳量表评估疲劳。中位VO2peak为25.1 mL O2·kg⁻¹·min⁻¹,78.6%患者低于年龄预测值;VO2peak与FACIT疲劳评分无显著关联(P=0.20)。
要点
- 28例早期乳腺癌放疗患者中,78.6%的VO2peak低于年龄预测值。
- 中位VO2peak为25.1 mL O2·kg⁻¹·min⁻¹,中位FACIT疲劳评分为41.5。
- VO2peak与FACIT疲劳评分无显著关联(P=0.20)。
核心结论
- VO2peak不是放疗相关疲劳的显著预测因素。
- 多数乳腺癌患者VO2peak提示心肺适能明显受损。
- 作者认为需要更大规模的前瞻性研究进一步探究这一新发现,并评估改善心肺适能的干预措施及其潜在预防疲劳的能力。
研究设计与样本
- 前瞻性先导研究,纳入28例Tis-T2N0M0期乳腺癌且ECOG体能状态0~1分、正在接受乳腺放疗的患者。
- 患者均在电动跑台上完成症状限制性心肺运动试验(CPET)以测定VO2peak,并用FACIT疲劳量表评估疲劳,两项评估均在放疗期间或刚结束时完成。
- 所有患者接受对穿切线野技术放疗,剂量4240 cGy分16次,伴或不伴瘤床加量;接受细胞毒性化疗的患者被排除。
- 采用Pearson相关系数和单因素线性回归分析VO2peak、疲劳与患者特征之间的关联。
主要发现
- 患者中位年龄52岁(范围31~71岁),中位VO2peak为25.1 mL O2·kg⁻¹·min⁻¹(范围16.7~41.7)。
- 78.6%的患者VO2peak低于其年龄预测值。
- 年龄和体重指数均与VO2peak水平显著相关。
- 中位FACIT疲劳评分为41.5(范围10~52),评分越低表示疲劳越重。
- VO2peak与FACIT疲劳评分无显著关联(P=0.20)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要更大规模的前瞻性研究进一步探究这一新发现,并评估改善心肺适能的干预措施及其潜在预防疲劳的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fatigue is among the most common but most poorly understood radiation therapy-associated toxicities. This prospective study sought to investigate whether cardiorespiratory fitness, an integrative measure of whole-body cardiopulmonary function, is associated with patient-reported fatigue in women with early-stage breast cancer undergoing radiation therapy. METHODS AND MATERIALS: Patients with stage Tis-T2N0M0 breast cancer and an Eastern Cooperative Oncology Group performance status of 0 to 1 undergoing breast radiation therapy performed a symptom-limited cardiopulmonary exercise test (CPET) on a motorized treadmill to assess cardiorespiratory fitness as measured by peak oxygen uptake (VO2peak). Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Scale. Both assessments were performed during or immediately after radiation therapy completion. All patients were treated with an opposed tangent technique to a dose of 4240 cGy in 16 fractions with or without a lumpectomy bed boost. Patients receiving cytotoxic chemotherapy were excluded. Pearson correlation coefficients and univariate linear regression were used to assess associations amongVO2peak, fatigue, and patient characteristics. RESULTS: Twenty-eight patients (median age, 52 years; range, 31-71) completed a CPET and FACIT-Fatigue assessment. Median VO2peak was 25.1 mL O2.kg-1.min-1 (range, 16.7-41.7). The majority of patients (78.6%) displayed a VO2peak lower than their age-predicted VO2peak. Both age and body mass index were significantly associated with VO2peak levels. The median FACIT-Fatigue score was 41.5 (range, 10-52), with lower values indicating more fatigue. VO2peak was not significantly associated with FACIT-Fatigue score (P = .20). CONCLUSIONS: VO2peak was not a significant predictor of radiation therapy-related fatigue. Most patients with breast cancer had marked impairments in cardiorespiratory fitness as determined by VO2peak. Larger prospective studies are needed to further investigate this novel finding and evaluate the effects of interventions aimed at improving cardiorespiratory fitness and their ability to potentially prevent fatigue.
引用
- Leeman JE, Lapen K, Fuchs HE, et al. Cardiorespiratory Fitness in Patients With Early-Stage Breast Cancer and Radiation Therapy-Related Fatigue: A Prospective Pilot Study. Int J Radiat Oncol Biol Phys. 2023. PMID: 37914143. doi:10.1016/j.ijrobp.2023.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。